AR020618A1 - Formulaciones en solucion estables de la hormona foliculoestimulante (fsh) y de variantes de fsh; procedimiento para preparar dichas formulaciones yarticulos de manufactura que comprenden dichas formulaciones - Google Patents
Formulaciones en solucion estables de la hormona foliculoestimulante (fsh) y de variantes de fsh; procedimiento para preparar dichas formulaciones yarticulos de manufactura que comprenden dichas formulacionesInfo
- Publication number
- AR020618A1 AR020618A1 ARP990103624A ARP990103624A AR020618A1 AR 020618 A1 AR020618 A1 AR 020618A1 AR P990103624 A ARP990103624 A AR P990103624A AR P990103624 A ARP990103624 A AR P990103624A AR 020618 A1 AR020618 A1 AR 020618A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulations
- fsh
- prepare
- variants
- stable solution
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 4
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 abstract 2
- 239000008363 phosphate buffer Substances 0.000 abstract 2
- 239000003755 preservative agent Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004288 Sodium dehydroacetate Substances 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- 229960003872 benzethonium Drugs 0.000 abstract 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 229960002242 chlorocresol Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 229940079839 sodium dehydroacetate Drugs 0.000 abstract 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 abstract 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 abstract 1
- 239000000021 stimulant Substances 0.000 abstract 1
- 238000011285 therapeutic regimen Methods 0.000 abstract 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 abstract 1
- 229940033663 thimerosal Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Dispersion Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se trata de formulaciones en solucion estables de foliculoestimulantes (FSH) y variantes de la misma caracterizadas porque comprende una FSH o unavariante de FSH conteniendo una subunidad alfa y una subunidad beta o sea: un agente conservador seleccionado del grupo que consiste de fenol, m-cresol, o-cresol, clorocresol, bencilalcohol, alquil tal como (metil, etil, propil, butil, parabeno y los similares) cloruro de benzalconio,cloruro de benzetonio,dehidroacetato de sodio, timerosal y mezclas delos mismos y un diluyente acuoso, o un buffer fosfatos que contiene sal o una solucion salina o ambos,conservadores y buffer fosfatos que contiene sal o solucion salina. También se propone un proceso para preparar dichas formulaciones y artículos demanufacturaque comprenden dichas formulaciones. Las formulaciones mencionadas son utiles en regímenes terapéuticos para incrementar los niveles séricos de FSH o devariantes de FSH durante los tratamientos. Por lo tanto inter alia la invencion proporciona productos de interés y conveniencia mejorada para tratamientos deinfertilidad.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9390698P | 1998-07-23 | 1998-07-23 | |
US9461198P | 1998-07-30 | 1998-07-30 | |
US9476798P | 1998-07-31 | 1998-07-31 | |
US9871198P | 1998-09-01 | 1998-09-01 | |
US10069698P | 1998-09-17 | 1998-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR020618A1 true AR020618A1 (es) | 2002-05-22 |
Family
ID=27536687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990103624A AR020618A1 (es) | 1998-07-23 | 1999-07-22 | Formulaciones en solucion estables de la hormona foliculoestimulante (fsh) y de variantes de fsh; procedimiento para preparar dichas formulaciones yarticulos de manufactura que comprenden dichas formulaciones |
Country Status (24)
Country | Link |
---|---|
EP (2) | EP1188444B1 (es) |
JP (1) | JP4719357B2 (es) |
KR (1) | KR20010083126A (es) |
CN (1) | CN1309567A (es) |
AR (1) | AR020618A1 (es) |
AT (2) | ATE308990T1 (es) |
AU (1) | AU776823B2 (es) |
BR (1) | BR9912243A (es) |
CA (1) | CA2335340C (es) |
CO (1) | CO5090905A1 (es) |
DE (2) | DE69928296T2 (es) |
DK (1) | DK0974359T4 (es) |
ES (2) | ES2183486T3 (es) |
HK (1) | HK1026615A1 (es) |
ID (1) | ID28747A (es) |
IL (1) | IL140984A0 (es) |
MY (1) | MY135913A (es) |
NO (1) | NO20010326L (es) |
NZ (1) | NZ508874A (es) |
PE (1) | PE20000939A1 (es) |
PL (1) | PL346127A1 (es) |
PT (1) | PT974359E (es) |
SI (1) | SI0974359T1 (es) |
WO (1) | WO2000004913A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6414123B1 (en) | 1997-10-21 | 2002-07-02 | Vitro Diagnostics, Inc. | Method for purifying FSH |
US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
JP2002541213A (ja) | 1999-04-13 | 2002-12-03 | インヘール セラピューティック システムズ, インコーポレイテッド | 不妊症の処置のための乾燥粉末処方物の肺投与 |
TWI318100B (en) | 2001-03-01 | 2009-12-11 | Lonza Ag | Preservative blends containing quaternary ammonium compounds |
AU2004226666B9 (en) * | 2003-04-02 | 2010-04-08 | Ares Trading S.A. | Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant |
SI1638595T1 (sl) | 2003-06-20 | 2013-04-30 | Ares Trading S.A. | Liofilizirane formulacije fsh/lh |
KR101105871B1 (ko) * | 2005-09-27 | 2012-01-16 | 주식회사 엘지생명과학 | 인 난포자극호르몬의 안정한 용액 제형 |
CA2685437C (en) * | 2007-02-08 | 2015-06-02 | Aspenbio Pharma, Inc. | Compositions and methods including expression and bioactivity of bovine follicle stimulating hormone |
SI2170942T1 (sl) | 2007-06-28 | 2013-12-31 | Biogenerix Ag | Produkcija celičnega klona folikle stimulirajočega hormona FSH |
JP5551601B2 (ja) * | 2007-11-01 | 2014-07-16 | メルク セローノ ソシエテ アノニム | Lh液体調製物 |
PL2249869T3 (pl) * | 2008-02-08 | 2012-02-29 | Theramex Hq Uk Ltd | Ciekły preparat FSH |
CN102309745B (zh) * | 2008-09-17 | 2013-05-08 | 上海天伟生物制药有限公司 | 一种卵泡刺激素冻干针剂 |
ES2558768T3 (es) | 2009-06-24 | 2016-02-08 | Tecpharma Licensing Ag | Dispositivo de administración con función de cebado |
EP2325194A1 (en) | 2009-11-24 | 2011-05-25 | Glycotope GmbH | Process for the purification of glycoproteins |
EP2515973B1 (de) | 2009-12-23 | 2018-02-21 | Tecpharma Licensing AG | Injektionsvorrichtung mit einer nadelschutzhülse |
WO2011076281A1 (de) | 2009-12-23 | 2011-06-30 | Tecpharma Licensing Ag | Entfernen einer nadelschutzkappe von einer nadel |
WO2011098129A1 (en) | 2010-02-11 | 2011-08-18 | Finox Ag | Injection training dummy |
WO2011099036A2 (en) * | 2010-02-12 | 2011-08-18 | Intas Biopharmaceuticals Limited | Liquid formulation of follicle stimulating hormone |
EP2417982A1 (en) * | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilization of gonadotropins |
WO2012142961A1 (zh) * | 2011-04-22 | 2012-10-26 | 上海天伟生物制药有限公司 | 一种低溶剂残留的糖蛋白组合物及其制备方法和用途 |
JP5750471B2 (ja) * | 2013-05-22 | 2015-07-22 | Jcrファーマ株式会社 | 組換え体ヒトfshの製造方法 |
CN103539860B (zh) * | 2013-11-01 | 2014-12-03 | 广州优联康医药科技有限公司 | 一种长效重组人促卵泡激素融合蛋白 |
CN103554269B (zh) * | 2013-11-01 | 2015-02-11 | 广州联康生物科技有限公司 | 重组猪促卵泡激素融合蛋白 |
CN103539861B (zh) * | 2013-11-01 | 2015-02-18 | 广州联康生物科技有限公司 | 长效重组人促卵泡激素融合蛋白 |
JP6166470B2 (ja) * | 2013-11-12 | 2017-07-19 | カディラ ヘルスケア リミティド | ゴナドトロピンのための新規製剤 |
AU2016323541A1 (en) * | 2015-09-17 | 2018-04-12 | Glycotope Gmbh | Mammalian follicle-stimulating hormone composition with increased stability |
GB201603280D0 (en) | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB839300A (en) * | 1957-09-05 | 1960-06-29 | Organon Labor Ltd | Adrenocorticotropic hormone preparations and process for making same |
US4659696A (en) † | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
US5162306A (en) * | 1987-01-23 | 1992-11-10 | Donaldson Lloyd E | Composition and method for producing superovulation in mammals |
IT1206302B (it) * | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
FR2623715B1 (fr) * | 1987-11-26 | 1990-12-21 | Lafon Labor | Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite |
US5733572A (en) * | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
MD1699F2 (ro) * | 1992-07-31 | 2001-07-31 | Genentech, Inc. | Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei |
US5661125A (en) * | 1992-08-06 | 1997-08-26 | Amgen, Inc. | Stable and preserved erythropoietin compositions |
US5594091A (en) † | 1994-02-21 | 1997-01-14 | Takeda Chemical Industries, Ltd. | Matrix for sustained-release preparation |
JP2758154B2 (ja) † | 1995-04-06 | 1998-05-28 | エフ・ホフマン−ラ ロシユ アーゲー | インターフェロンを含む液体製剤 |
ATE255903T1 (de) * | 1995-11-07 | 2003-12-15 | Genentech Inc | Stabilisierende formulierung für ngf |
GB2317010A (en) * | 1996-09-04 | 1998-03-11 | Eev Ltd | Gas sensor detecting only non-reflected light |
TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
US6287587B2 (en) † | 1997-07-15 | 2001-09-11 | Takeda Chemical Industries, Ltd. | Process for producing sustained-release preparation by in-water drying |
MY120063A (en) * | 1997-12-09 | 2005-08-30 | Lilly Co Eli | Stabilized teriparatide solutions |
JP2000151148A (ja) * | 1998-11-13 | 2000-05-30 | Mitsumi Electric Co Ltd | 携帯用電子機器のコード接続構造 |
-
1999
- 1999-07-15 WO PCT/US1999/016031 patent/WO2000004913A1/en not_active Application Discontinuation
- 1999-07-15 NZ NZ508874A patent/NZ508874A/xx unknown
- 1999-07-15 PL PL99346127A patent/PL346127A1/xx not_active Application Discontinuation
- 1999-07-15 IL IL14098499A patent/IL140984A0/xx unknown
- 1999-07-15 AU AU49980/99A patent/AU776823B2/en not_active Expired
- 1999-07-15 BR BR9912243-0A patent/BR9912243A/pt not_active IP Right Cessation
- 1999-07-15 JP JP2000560906A patent/JP4719357B2/ja not_active Expired - Lifetime
- 1999-07-15 CA CA2335340A patent/CA2335340C/en not_active Expired - Lifetime
- 1999-07-15 ID IDW20010141A patent/ID28747A/id unknown
- 1999-07-15 KR KR1020017000781A patent/KR20010083126A/ko not_active Application Discontinuation
- 1999-07-15 CN CN99808813A patent/CN1309567A/zh active Pending
- 1999-07-16 DE DE69928296T patent/DE69928296T2/de not_active Expired - Lifetime
- 1999-07-16 AT AT01130213T patent/ATE308990T1/de active
- 1999-07-16 DE DE69904262T patent/DE69904262T3/de not_active Expired - Lifetime
- 1999-07-16 DK DK99305664T patent/DK0974359T4/da active
- 1999-07-16 EP EP01130213A patent/EP1188444B1/en not_active Revoked
- 1999-07-16 SI SI9930156T patent/SI0974359T1/xx unknown
- 1999-07-16 EP EP99305664A patent/EP0974359B2/en not_active Expired - Lifetime
- 1999-07-16 ES ES99305664T patent/ES2183486T3/es not_active Expired - Lifetime
- 1999-07-16 PT PT99305664T patent/PT974359E/pt unknown
- 1999-07-16 ES ES01130213T patent/ES2250290T3/es not_active Expired - Lifetime
- 1999-07-16 AT AT99305664T patent/ATE228850T1/de active
- 1999-07-21 CO CO99045916A patent/CO5090905A1/es unknown
- 1999-07-22 MY MYPI99003089A patent/MY135913A/en unknown
- 1999-07-22 AR ARP990103624A patent/AR020618A1/es not_active Application Discontinuation
- 1999-07-22 PE PE1999000738A patent/PE20000939A1/es not_active Application Discontinuation
-
2000
- 2000-07-24 HK HK00104578A patent/HK1026615A1/xx not_active IP Right Cessation
-
2001
- 2001-01-19 NO NO20010326A patent/NO20010326L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR020618A1 (es) | Formulaciones en solucion estables de la hormona foliculoestimulante (fsh) y de variantes de fsh; procedimiento para preparar dichas formulaciones yarticulos de manufactura que comprenden dichas formulaciones | |
ES2163236T3 (es) | Preparacion de 1,1,1,3,3-pentafluoropropano. | |
ES2068403T3 (es) | Productos herbicidas. | |
ES2174027T3 (es) | Composiciones estables que contienen macrolidos y macrolidos combinados con unas vacunas. | |
AR012671A1 (es) | Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos | |
GR3006798T3 (es) | ||
PT95343A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo doses baixas de um agente anticoagulante oral tal como o warfarin e de um inibidor de plaquetas tal como o acido acetilsalilico,como ingredientes acticovos apropriadas para otratamento e/ou prevencao de doencas cardiacas | |
PE36795A1 (es) | Complejo de inclusion en solucion acuosa de compuestos de benzotiofeno con ciclodextrinas solubles en agua, formulaciones farmaceuticas y procedimiento de obtencion | |
PT83933B (pt) | Processo para a preparacao de composicoes estaveis de activador do plasminogenio humano, tipo tecido | |
CA2034484A1 (en) | Radioimmunotherapy using .alpha.-particles emission | |
PT89125A (pt) | Processo para a preparacao de uma composicao de enxaguamento de tecidos para remocao de residuos de agente tensio-activo, contendo baixos niveis de um agente tensio-activo nao ionico e um acido organico | |
ES2055098T3 (es) | Metodo y composicion para la afinacion de superficies metalicas. | |
DE58905235D1 (de) | Wasch- und reinigungsmittel. | |
FR2459279B1 (fr) | Composition detergente liquide contenant un systeme adjuvant actif | |
AR010716A1 (es) | Formulacion para tabletas efervecentes desinfectantes y metodo para formar una solucion desinfectante | |
BR0014895A (pt) | Formulação lìquida estável, processo para a preparação da mesma, uso da mesma, uso de polietileno glicol e sal de sódio ou potássio de um inibidor h+, k+-atpase, e, método para tratar doenças gastrointestinais | |
MX169812B (es) | Mejoras a composicion detergente liquida acuosa tixotropica para el lavado automatico de platos | |
TR27442A (tr) | Sivi asindirici temizleme terkibi. | |
ES2111032T5 (es) | Carboxialquil polisacaridos y procedimiento de fabricacion de los mismos. | |
PE20001377A1 (es) | Una composicion de alta pureza de (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona | |
MX167823B (es) | Procedimiento para preparar 2-amino-6-cloroporina | |
MX172107B (es) | Procedimiento para la desinfeccion de masas para vaciado medicinales | |
MC1930A1 (fr) | Produit antiviral | |
JPS5756420A (en) | Bath agent | |
AR021577A1 (es) | Preparado con una amplitud terapeutica mejorada, que contiene inhibidores de la sintesis de los nucleotidos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |